Topics:
Pediatric Oncology • Thrombocytopenia • Hematology • Pediatric Hematology • Plasma exchange • Benign Hematology
When should you use caplacizumab in the treatment of acute TTP patients?
Answer from: at Academic Institution
Whenever I encounter a patient with features of thrombotic microangiopathy and a normal coagulation panel (that rules out DIC), I consider the possibility they may have immune TTP.If my suspicion of immune TTP is high (e.g. history of autoimmune disease, possible relapse of immune TTP) and there is ...
Sign in or Register to read more